Feasibility, safety and effectiveness of prednisolone and vitamin B1, B6, and B12 in patients with post-COVID-19-syndrome (PreVitaCOV) – protocol of a randomised, double-blind, placebo-controlled multicentre trial in primary care (phase IIIb)

Peer Review reports

Original Submission
6 Dec 2023	Submitted	Original manuscript
13 Dec 2023	Author responded	Author comments - Christian Förster
Resubmission - Version 2
13 Dec 2023	Submitted	Manuscript version 2
Publishing
18 Dec 2023	Editorially accepted
6 Jan 2024	Article published	10.1186/s12879-023-08925-2

Back to article page